Swiss National Bank Atara Biotherapeutics, Inc. Transaction History

Swiss National Bank

$140 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$2.8 - $5.46 $55,160 - $107,562	-19,700 Reduced 10.17%	174,000 $504,000
Q4 2022 Feb 08, 2023	BUY	$2.85 - $5.18 $20,805 - $37,814	7,300 Added 3.92%	193,700 $635,000
Q2 2022 Aug 09, 2022	BUY	$4.69 - $9.84 $40,803 - $85,608	8,700 Added 4.9%	186,400 $1.45 Million
Q1 2022 May 09, 2022	BUY	$8.44 - $16.89 $167,112 - $334,422	19,800 Added 12.54%	177,700 $1.65 Million
Q3 2021 Nov 08, 2021	BUY	$11.99 - $17.9 $14,388 - $21,480	1,200 Added 0.77%	157,900 $2.83 Million

Q2 2021 Aug 06, 2021	SELL	$12.89 - $16.58 $153,391 - $197,301	-11,900 Reduced 7.06%	156,700 $2.44 Million
Q1 2021 May 07, 2021	BUY	$14.0 - $20.72 $126,000 - $186,480	9,000 Added 5.64%	168,600 $2.42 Million
Q4 2020 Feb 05, 2021	BUY	$12.67 - $26.23 $69,685 - $144,265	5,500 Added 3.57%	159,600 $3.13 Million
Q3 2020 Nov 09, 2020	BUY	$11.92 - $15.87 $27,416 - $36,501	2,300 Added 1.52%	154,100 $2 Million
Q2 2020 Aug 05, 2020	BUY	$7.53 - $14.93 $431,469 - $855,489	57,300 Added 60.63%	151,800 $2.21 Million
Q1 2020 May 08, 2020	BUY	$5.69 - $17.78 $11,380 - $35,560	2,000 Added 2.16%	94,500 $804,000
Q4 2019 Feb 06, 2020	BUY	$10.89 - $16.79 $39,204 - $60,444	3,600 Added 4.05%	92,500 $1.52 Million
Q3 2019 Nov 12, 2019	BUY	$12.03 - $19.94 $139,548 - $231,304	11,600 Added 15.01%	88,900 $1.26 Million
Q2 2019 Aug 02, 2019	BUY	$19.05 - $41.04 $361,950 - $779,760	19,000 Added 32.59%	77,300 $1.56 Million
Q1 2019 May 10, 2019	BUY	$28.4 - $41.74 $62,480 - $91,828	2,200 Added 3.92%	58,300 $2.32 Million
Q4 2018 Feb 13, 2019	BUY	$30.9 - $42.97 $108,150 - $150,395	3,500 Added 6.65%	56,100 $1.95 Million
Q1 2018 May 04, 2018	BUY	$18.0 - $48.35 $432,000 - $1.16 Million	24,000 Added 83.92%	52,600 $2.05 Million
Q3 2017 Nov 03, 2017	BUY	$13.25 - $17.05 $378,950 - $487,630	28,600	28,600 $473,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

Eco R1 Capital, LLC San Francisco, CA

10.2M
Shares

$78.4 Million
0.2% of portfolio
Redmile Group, LLC San Francisco, CA

9.26M
Shares

$71.4 Million
0.25% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$52.7 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

6.58M
Shares

$50.7 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

6.51M
Shares

$50.2 Million
0.0% of portfolio

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account